Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 9—September 2022

Fulminant Transfusion-Associated Hepatitis E Virus Infection Despite Screening, England, 2016–2020

Heli HarvalaComments to Author , Claire Reynolds, Su Brailsford, and Katy Davison
Author affiliations: University College of London, London, UK (H. Harvala); NHS Blood and Transplant, London (H. Harvala, C. Reynolds, S. Brailsford, K. Davison); UK Health Security Agency, London (K. Davison)

Main Article

Table 4

Nondetection of HEV RNA based on retrospective investigations for apheresis donors, in which indicated donations are individually retested for HEV RNA, England, March 2016 to–December 2020

Year(s) Screening
Previous donations
No. apheresis donations screened No. HEV RNA–positive donations No. retrospectively tested No. HEV RNA–positive donations identified by retesting No. components produced and supplied for clinical use
2016–2017 144,027 44 35 2 4
2018 70,709 24 24 3 6
2019 68,907 15 14 2 4
2020 66,680 24 25 2 4
Total 350,323 107 98 9 18

Main Article

Page created: July 14, 2022
Page updated: August 19, 2022
Page reviewed: August 19, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.